Related Experiment Video
Updated: Mar 17, 2026

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
SPATA2 promotes CYLD activity and regulates TNF-induced NF-κB signaling and cell death
Lisa Schlicher1, Manuela Wissler2, Florian Preiss3
1Institute of Molecular Medicine and Cell Research, Albert-Ludwigs-University Freiburg, Freiburg, Germany Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University of Freiburg, Freiburg, Germany BIOSS, Centre for Biological Signaling Studies, Freiburg, Germany.
Abstract:
K63- and Met1-linked ubiquitylation are crucial posttranslational modifications for TNF receptor signaling. These non-degradative ubiquitylations are counteracted by deubiquitinases (DUBs), such as the enzyme CYLD, resulting in an appropriate signal strength, but the regulation of this process remains incompletely understood. Here, we describe an interaction partner of CYLD, SPATA2, which we identified by a mass spectrometry screen. We find that SPATA2 interacts via its PUB domain with CYLD, while a PUB interaction motif (PIM) of SPATA2 interacts with the PUB domain of the LUBAC component HOIP SPATA2 is required for the recruitment of CYLD to the TNF receptor signaling complex upon TNFR stimulation. Moreover, SPATA2 acts as an allosteric activator for the K63- and M1-deubiquitinase activity of CYLD In consequence, SPATA2 substantially attenuates TNF-induced NF-κB and MAPK signaling. Conversely, SPATA2 is required for TNF-induced complex II formation, caspase activation, and apoptosis. Thus, this study identifies SPATA2 as an important factor in the TNF signaling pathway with a substantial role for the effects mediated by the cytokine.
Insights
SPATA2 interacts with CYLD, an enzyme that regulates TNF receptor signaling. SPATA2 activates CYLD
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Tumor Necrosis Factor (TNF) receptor signaling involves K63- and Met1-linked ubiquitylation.
- Deubiquitinases (DUBs), like CYLD, regulate these modifications to control signal strength.
- The precise regulation of CYLD's activity in TNF signaling is not fully understood.
Purpose of the Study:
- To identify novel regulators of CYLD in TNF receptor signaling.
- To elucidate the mechanism by which SPATA2 influences CYLD activity and TNF pathway outcomes.
Main Methods:
- Mass spectrometry to identify CYLD interaction partners.
- Co-immunoprecipitation and Western blotting to confirm protein interactions.
- Analysis of NF-κB and MAPK pathway activation, complex II formation, and apoptosis in response to TNF stimulation.
Main Results:
- SPATA2 was identified as a CYLD interaction partner, binding via its PUB domain.
- SPATA2's PUB interaction motif (PIM) binds to the LUBAC component HOIP.
- SPATA2 is essential for recruiting CYLD to the TNF receptor complex and allosterically activates CYLD's deubiquitinase activity.
- SPATA2 attenuates TNF-induced NF-κB and MAPK signaling but is required for TNF-induced apoptosis.
Conclusions:
- SPATA2 is a critical regulator of TNF receptor signaling by modulating CYLD activity.
- SPATA2 plays a dual role in TNF signaling, inhibiting pro-survival pathways while promoting apoptosis.
- This discovery highlights SPATA2 as a key factor influencing the diverse effects of TNF.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The Extrinsic Apoptotic Pathway
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
Caspases
NF-kB-dependent Signaling Pathway

